Helping kids hear the future
Fennec Pharmaceuticals is a biotechnology company dedicated to improving the lives of children with cancer who experience hearing loss as a result of chemotherapy.
Latest News
- Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
- Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
- FENNEC PHAMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
- FENNEC PHARMACEUTICALS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
- FENNEC PHARMACEUTICALS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 13, 2024